Pharma Journalist 9038 posts 0 comments

Axis Therapeutics Limited, a joint venture between Athenex, Inc. and Xiangxue Life Sciences Limited, focused on the research, development, and commercialization of T cell immunotherapy,…
Read More...

CStone Pharmaceuticals announced the completion of the Share Subscription Agreement through which an affiliate of Pfizer Inc. subscribed for newly issued CStone shares at approximately…
Read More...

SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference. SMi Group is delighted to announce the return of the successful 3D Cell Culture…
Read More...

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces that it received investigational new drug application (IND) approval from FDA for its drug candidate…
Read More...

SMi Reports: Pre-filled Syringes East Coast 2020 virtual conference only 2 weeks away The upcoming conference now only 2 weeks away will bring together specialists within the…
Read More...

As the number of COVID-19 cases and deaths continues to rise in most countries, Australian clinical-stage drug development company Noxopharm is pleased to announce treatment of the…
Read More...

Qualigen Therapeutics, Inc. announces it has entered into an agreement with Yi Xin Zhen Duan Jishu (Suzhou) Ltd, of Suzhou, China to develop, manufacture and sell new generations of…
Read More...

Johnson & Johnson announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen…
Read More...

Takeda Pharmaceutical Company Limited and Arrowhead Pharmaceuticals Inc. announced a collaboration and licensing agreement to develop ARO-AAT, a Phase 2 investigational RNA interference…
Read More...

Pfizer Inc. and Sangamo Therapeutics, Inc. a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of giroctocogene…
Read More...